NCT02780726 - A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 22, 2016

Primary Completion Date

August 2, 2017

Study Completion Date

August 2, 2017

Conditions

Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

Interventions

DRUG

roxadustat

Oral

Trial Locations (15)

Site JP00002, Aichi

Site JP00004, Aichi

Site JP00010, Aichi

Site JP00013, Aichi

Site JP00001, Fukuoka

Site JP00005, Fukuoka

Site JP00012, Hokkaido

Site JP00014, Hokkaido

Site JP00006, Ishikawa

Site JP00008, Kanagawa

Site JP00003, Nagano

SIte JP00015, Okayama

Site JP00009, Osaka

Site JP00007, Tokushima

Site JP00011, Toyama